Total Payments
$1,560
2024 Payments
$308.05
Companies
26
Transactions
57
Medicare Patients
589
Medicare Billing
$55,374
Payment Breakdown by Category
Food & Beverage$1,291 (82.8%)
Education$268.98 (17.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,291 | 54 | 82.8% |
| Education | $268.98 | 3 | 17.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $180.00 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $172.12 | 3 | $0 (2023) |
| ABBVIE INC. | $165.99 | 5 | $0 (2024) |
| Genentech USA, Inc. | $105.04 | 5 | $0 (2024) |
| Mirati Therapeutics, Inc. | $92.67 | 1 | $0 (2024) |
| Seagen Inc. | $88.85 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $87.01 | 3 | $0 (2023) |
| Pharmacyclics LLC, An AbbVie Company | $65.07 | 3 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $63.89 | 3 | $0 (2023) |
| Janssen Biotech, Inc. | $59.59 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $308.05 | 8 | ABBVIE INC. ($131.90) |
| 2023 | $1,052 | 43 | AstraZeneca Pharmaceuticals LP ($172.12) |
| 2022 | $199.54 | 6 | Incyte Corporation ($99.00) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: ONCOLOGY | ||||||
| 05/29/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $5.32 | General |
| Category: ONCOLOGY | ||||||
| 04/03/2024 | Genentech USA, Inc. | Kadcyla (Biological), Perjeta, Phesgo | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: BioOncology | ||||||
| 04/02/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: ONCOLOGY | ||||||
| 03/26/2024 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: BioOncology | ||||||
| 03/26/2024 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: BioOncology | ||||||
| 03/20/2024 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $20.94 | General |
| 02/13/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $92.67 | General |
| Category: Oncology | ||||||
| 12/12/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2023 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Oncology | ||||||
| 10/24/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: ONCOLOGY | ||||||
| 09/14/2023 | G1 Therapeutics, Inc. | COSELA (Drug) | Food and Beverage | Cash or cash equivalent | $24.94 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Hematology/Oncology | ||||||
| 08/24/2023 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Oncology | ||||||
| 08/23/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Respiratory | ||||||
| 08/14/2023 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Oncology | ||||||
| 08/08/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $130.57 | General |
| Category: Oncology | ||||||
| 07/21/2023 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2023 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Oncology | ||||||
| 07/17/2023 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $19.19 | General |
| 07/11/2023 | PFIZER INC. | IBRANCE (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: ONCOLOGY | ||||||
| 07/06/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Oncology | ||||||
| 07/05/2023 | Puma Biotechnology, Inc. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 535 | 1,314 | $151,363 | $50,521 |
| 2022 | 2 | 54 | 60 | $12,876 | $4,853 |
Total Patients
589
Total Services
1,374
Medicare Billing
$55,374
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 374 | $85,646 | $32,054 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 99 | $15,543 | $5,692 | 36.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 24 | $7,368 | $3,015 | 40.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 70 | 230 | $12,650 | $2,381 | 18.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 78 | 246 | $4,920 | $2,059 | 41.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 16 | 18 | $6,840 | $1,680 | 24.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 71 | 211 | $8,440 | $1,606 | 19.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 16 | 20 | $4,020 | $896.35 | 22.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 16 | 54 | $4,644 | $888.84 | 19.1% |
| 83735 | Magnesium level | Office | 2023 | 12 | 38 | $1,292 | $249.66 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 48 | $10,992 | $4,199 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,884 | $654.04 | 34.7% |
About Sheila Erasmus, NP-C
Sheila Erasmus, NP-C is a Nurse Practitioner healthcare provider based in Lisle, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2021. The National Provider Identifier (NPI) number assigned to this provider is 1588324883.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sheila Erasmus, NP-C has received a total of $1,560 in payments from pharmaceutical and medical device companies, with $308.05 received in 2024. These payments were reported across 57 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,291).
As a Medicare-enrolled provider, Erasmus has provided services to 589 Medicare beneficiaries, totaling 1,374 services with total Medicare billing of $55,374. Data is available for 2 years (2022–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Nurse Practitioner
- Location Lisle, IL
- Active Since 12/28/2021
- Last Updated 05/12/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1588324883
Products in Payments
- VENCLEXTA (Drug) $152.80
- IMFINZI (Biological) $130.57
- KRAZATI (Drug) $92.67
- LIBTAYO (Biological) $87.01
- JAKAFI (Drug) $81.00
- ICLUSIG (Drug) $63.89
- KEYTRUDA (Biological) $59.17
- Pomalyst (Drug) $48.84
- COSELA (Drug) $48.01
- Trodelvy (Drug) $42.42
- IMBRUVICA (Drug) $35.66
- Tecentriq (Biological) $32.79
- Kadcyla (Biological) $29.75
- EPKINLY (Drug) $29.41
- VERZENIO (Drug) $27.06
- NERLYNX (Drug) $25.11
- Tibsovo (Drug) $24.54
- Lunsumio (Biological) $24.28
- INJECTAFER (Drug) $23.11
- TAGRISSO (Drug) $21.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Lisle
Mrs. Jennifer Jump, Aprn Fnp-Bc, APRN FNP-BC
Nurse Practitioner — Payments: $4,564
Nurse Practitioner $4,564
Rosaleen Lim, Apn, APN
Nurse Practitioner — Payments: $1,998
Nurse Practitioner $1,998
Sarah Ramsland, Apn, Cnp, APN, CNP
Nurse Practitioner — Payments: $866.59
Nurse Practitioner $866.59
Jennifer Buening, Apn, Fnp-C, APN, FNP-C
Nurse Practitioner — Payments: $727.75
Nurse Practitioner $727.75
Michael Taccona, Aprn, Fnp-C, APRN, FNP-C
Nurse Practitioner — Payments: $719.30
Nurse Practitioner $719.30
Emma Servatius
Nurse Practitioner — Payments: $597.97
Nurse Practitioner $597.97